|
1
|
Trotter SC, Sroa N, Winkelmann RR, Olencki
T and Bechtel M: A global review of melanoma follow-up guidelines.
J Clin Aesthet Dermatol. 6:18–26. 2013.
|
|
2
|
Linos E, Swetter SM, Cockburn MG, Colditz
GA and Clarke CA: Increasing burden of melanoma in the United
States. J Invest Dermatol. 129:1666–1674. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wagenseller AG, Shada A, D’Auria KM, et
al: MicroRNAs induced in melanoma treated with combination targeted
therapy of Temsirolimus and Bevacizumab. J Transl Med. 11:2182013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Margue C, Philippidou D, Reinsbach SE, et
al: New target genes of MITF-induced microRNA-211 contribute to
melanoma cell invasion. PLoS One. 8:e734732013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kozubek J, Ma Z, Fleming E, et al:
In-depth characterization of microRNA transcriptome in melanoma.
PLoS One. 8:e726992013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu X, Jiang X, Li H, Guo L, Jiang W and Lu
SH: miR-203 inhibits the proliferation and self-renewal of
esophageal cancer stem-like cells by suppressing stem renewal
factor Bmi-1. Stem Cells Dev. 23:576–585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang C, Wang X, Liang H, et al: miR-203
inhibits cell proliferation and migration of lung cancer cells by
targeting PKCα. PLoS One. 8:e739852013.PubMed/NCBI
|
|
9
|
Noguchi S, Kumazaki M, Yasui Y, et al:
MicroRNA-203 regulates melanosome transport and tyrosinase
expression in melanoma cells by targeting kinesin superfamily
protein 5b. J Invest Dermatol. 134:461–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Kempen LC, van den Hurk K, Lazar V, et
al: Loss of microRNA-200a and c, and microRNA-203 expression at the
invasive front of primary cutaneous melanoma is associated with
increased thickness and disease progression. Virchows Arch.
461:441–448. 2012.PubMed/NCBI
|
|
11
|
Wang X, Hu G and Zhou J: Repression of
versican expression by microRNA-143. J Biol Chem. 285:23241–23250.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hernández D, Miquel-Serra L, Docampo MJ,
Marco-Ramell A and Bassols A: Role of versican V0/V1 and CD44 in
the regulation of human melanoma cell behavior. Int J Mol Med.
27:269–275. 2011.PubMed/NCBI
|
|
13
|
Choi E, Choi E and Hwang KC: MicroRNAs as
novel regulators of stem cell fate. World J Stem Cells. 5:172–187.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hauptman N and Glavac D: MicroRNAs and
long non-coding RNAs: prospects in diagnostics and therapy of
cancer. Radiol Oncol. 47:311–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu Y, Brenn T, Brown ER, Doherty V and
Melton DW: Differential expression of microRNAs during melanoma
progression: miR-200c, miR-205 and miR-211 are downregulated in
melanoma and act as tumour suppressors. Br J Cancer. 106:553–561.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noguchi S, Mori T, Hoshino Y, et al:
MicroRNAs as tumour suppressors in canine and human melanoma cells
and as a prognostic factor in canine melanomas. Vet Comp Oncol. Dec
8–2011.(Epub ahead of print).
|
|
17
|
Du WW, Yang W and Yee AJ: Roles of
versican in cancer biology - tumorigenesis, progression and
metastasis. Histol Histopathol. 28:701–713. 2013.PubMed/NCBI
|
|
18
|
Touab M, Villena J, Barranco C, Arumí-Uría
M and Bassols A: Versican is differentially expressed in human
melanoma and may play a role in tumor development. Am J Pathol.
160:549–557. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gambichler T, Kreuter A, Grothe S, et al:
Versican overexpression in cutaneous malignant melanoma. Eur J Med
Res. 13:500–504. 2008.PubMed/NCBI
|
|
20
|
Morton SU, Scherz PJ, Cordes KR, et al:
microRNA-138 modulates cardiac patterning during embryonic
development. Proc Natl Acad Sci USA. 105:17830–17835. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee DY, Shatseva T, Jeyapalan Z, et al: A
3′-untranslated region (3′UTR) induces organ adhesion by regulating
miR-199a* functions. PLoS One. 4:e45272009.
|
|
22
|
Noguchi S, Mori T, Otsuka Y, et al:
Anti-oncogenic microRNA-203 induces senescence by targeting E2F3
protein in human melanoma cells. J Biol Chem. 287:11769–11777.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Du WW, Yang BB, Shatseva TA, et al:
Versican G3 promotes mouse mammary tumor cell growth, migration,
and metastasis by influencing EGF receptor signaling. PLoS One.
5:e138282010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ween MP, Hummitzsch K, Rodgers RJ, Oehler
MK and Ricciardelli C: Versican induces a pro-metastatic ovarian
cancer cell behavior which can be inhibited by small hyaluronan
oligosaccharides. Clin Exp Metastasis. 28:113–125. 2011. View Article : Google Scholar : PubMed/NCBI
|
